Sanofi Discusses Collaboration on Biotech and Pharma in Iraq
The Iraqi Ministry of Health has held high-level discussions with a delegation from French pharmaceutical company Sanofi, aimed at strengthening collaboration on biopharmaceutical development, healthcare capacity-building, and policy modernisation.
The meeting was chaired by Health Minister Dr. Saleh Mahdi Al-Hasnawi, who welcomed Sanofi's delegation led by Dr. Rami Nassar. The minister emphasised the importance of international partnerships in supporting Iraq's health sector, affirming the ministry's commitment to aligning pharmaceutical policy with global standards.
As part of the ongoing collaboration, the two sides discussed the enhancement of the "Imkan" programme, a joint initiative to improve Iraq's healthcare delivery and provide advanced training for medical personnel.
Separately, the Ministry's Directorate of Specialised Centres held a three-day scientific workshop titled "Biosimilars and Intellectual Property: Shaping Future Policy Based on Regional Experiences," under the "Imkan" programme and in partnership with Sanofi. The workshop explored regulatory frameworks for biosimilars, intellectual property rights, and evidence-based pharmaceutical policies.
Speaking on behalf of the minister, Technical Deputy Dr. Hani Al-Aqabi reiterated Iraq's intention to build strategic partnerships with global healthcare leaders. He highlighted the importance of updating Iraq's pharmaceutical regulations while protecting intellectual property and supporting local industry in line with government directives.
Dr. Ahmed Abbadi, Director of Specialised Centres, described the workshop as a vital platform for exchanging expertise. Participants included representatives from the Jordanian Food and Drug Administration, the Lebanese Ministry of Health, and various senior Iraqi health officials.
The event concluded with a recognition ceremony, awarding the "Imkan Shield" to key contributors from the ministry and Sanofi, reflecting their role in strengthening Iraq's healthcare infrastructure.
(Source: Ministry of Health)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Iraq Business
3 days ago
- Iraq Business
Sanofi Discusses Collaboration on Biotech and Pharma in Iraq
By John Lee. The Iraqi Ministry of Health has held high-level discussions with a delegation from French pharmaceutical company Sanofi, aimed at strengthening collaboration on biopharmaceutical development, healthcare capacity-building, and policy modernisation. The meeting was chaired by Health Minister Dr. Saleh Mahdi Al-Hasnawi, who welcomed Sanofi's delegation led by Dr. Rami Nassar. The minister emphasised the importance of international partnerships in supporting Iraq's health sector, affirming the ministry's commitment to aligning pharmaceutical policy with global standards. As part of the ongoing collaboration, the two sides discussed the enhancement of the "Imkan" programme, a joint initiative to improve Iraq's healthcare delivery and provide advanced training for medical personnel. Separately, the Ministry's Directorate of Specialised Centres held a three-day scientific workshop titled "Biosimilars and Intellectual Property: Shaping Future Policy Based on Regional Experiences," under the "Imkan" programme and in partnership with Sanofi. The workshop explored regulatory frameworks for biosimilars, intellectual property rights, and evidence-based pharmaceutical policies. Speaking on behalf of the minister, Technical Deputy Dr. Hani Al-Aqabi reiterated Iraq's intention to build strategic partnerships with global healthcare leaders. He highlighted the importance of updating Iraq's pharmaceutical regulations while protecting intellectual property and supporting local industry in line with government directives. Dr. Ahmed Abbadi, Director of Specialised Centres, described the workshop as a vital platform for exchanging expertise. Participants included representatives from the Jordanian Food and Drug Administration, the Lebanese Ministry of Health, and various senior Iraqi health officials. The event concluded with a recognition ceremony, awarding the "Imkan Shield" to key contributors from the ministry and Sanofi, reflecting their role in strengthening Iraq's healthcare infrastructure. (Source: Ministry of Health)
Shafaq News
3 days ago
- Shafaq News
Iraq grants patents for cancer therapy and smart tech innovations
Shafaq News – Baghdad Iraq's Directorate of Patents and Industrial Designs has granted four new patents for scientific innovations in cancer treatment, sustainable architecture, soil monitoring, and water management, the Central Organization for Standardization and Quality Control announced on Monday. In a statement, the directorate detailed the awarded patents, including a gold-based compound derived from sulfadiazine for breast cancer treatment, developed by researchers at the University of Kufa. The compound has demonstrated promising results in inhibiting cancer cell growth. Also recognized was the "Heliodon Device" from the University of Technology, which is designed to analyze the impact of sunlight on architectural structures, providing data to optimize building designs for environmental efficiency. A third patent was issued for the "Dual Automatic Lysimeter-Hygrometer," a smart system capable of measuring key soil and water properties to aid agricultural planning and land evaluation. The fourth innovation, the "Wireless Float Valve," aims to improve the efficiency of water pumping systems, particularly in areas with limited access to automated infrastructure. The head of the Central Organization for Standardization and Quality Control, Fayadh Mohammed Abd, praised the achievements, stating that they 'reflect the growing capacity of Iraqi researchers and mark a significant step forward in the country's scientific development.' Mohammed Jamal Jassim, Director of the Patents and Industrial Designs Directorate, noted that all the awarded innovations underwent rigorous evaluation per international standards.
Iraqi News
4 days ago
- Iraqi News
France's Sanofi helps Iraq develop pharmaceutical industry
Baghdad ( – The Iraqi Ministry of Health mentioned on Sunday that the agreement with Sanofi, a French pharmaceutical and healthcare company, represents an essential step toward strengthening Iraq's pharmaceutical industry. During his participation in a scientific workshop on biosimilar medicines and intellectual property, Deputy Health Minister Hani al-Oqabi explained that the agreement reached with Sanofi is not limited to the pharmaceutical industry but includes other important areas, according to the state-run news agency (INA). Iraqi Prime Minister Mohammed Shia al-Sudani has lately been focusing on developing collaboration with international enterprises and seeking investments to build industries in Iraq, according to al-Oqabi. The prime minister's advisor on industry and private sector development, Hammoudi al-Lami, revealed earlier that AstraZeneca, a British-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, is thinking of building a pharmaceutical facility in Iraq. In a statement to the Iraqi News Agency (INA), al-Lami explained that Arab and foreign companies are eager to set up businesses in the Iraqi market. The Iraqi official indicated that the US multinational healthcare company Baxter, as well as businesses in the Gulf States, had also expressed a desire to become part of the Iraqi market. The Iraqi Ministry of Health revealed in late April that it signed an agreement with European companies to establish an insulin production plant in the northern Iraqi province of Nineveh. According to INA, the agreement was signed with a Polish firm, one of the top four producers of insulin worldwide, and a German corporation. The idea to produce insulin in Iraq that meets all European requirements was sparked by the Iraqi government's support for pharmaceutical and health industry initiatives. The steps align with the objectives outlined in the Iraqi government's agenda, which emphasizes the development of the country's health sector.
